These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4006646)

  • 21. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies on dissolution of gallstones using ursodeoxycholic acid.
    Okumura M; Tanikawa K; Chúman Y; Kóji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
    Gastroenterol Jpn; 1977; 12(6):469-75. PubMed ID: 608570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholelitholysis--gallbladder sediments and pigment stones].
    Wolpers C; Wosiewitz U
    Leber Magen Darm; 1985 Mar; 15(2):64-70. PubMed ID: 3990499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dissolution of biliary calculi with CDCA and UDCA].
    Sugata F
    Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
    Bocharova LV; Genia LP; Lemeshko ZA; Petrova EA
    Lab Delo; 1989; (3):59-61. PubMed ID: 2469846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best-buy regimen of ursodeoxycholic acid for patients with gallstones.
    Lanzini A; Facchinetti D; Pigozzi MG; Bettini L; Muiesan G
    Scand J Gastroenterol; 1991 May; 26(5):551-6. PubMed ID: 1871547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of calcified gallstone dissolved by UDCA treatment].
    Takeuchi T; Hachiya H; Miyazi M; Hayakawa T; Hoshino M; Katagiri K; Yamamoto T; Maeda K; Tachi Y
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2080-5. PubMed ID: 3795579
    [No Abstract]   [Full Text] [Related]  

  • 33. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
    Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
    Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
    Podda M; Ghezzi C; Battezzati PM; Crosignani A; Zuin M; Roda A
    Gastroenterology; 1990 Apr; 98(4):1044-50. PubMed ID: 1968871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the purified unsaponifiable fraction of soybean in combination with ursodeoxycholic acid on cholesterol saturation of bile and stone dissolution in gallstone patients.
    Kajiyama G; Kawamoto T; Fujiyama M; Maruhashi A; Miyoshi A
    Hiroshima J Med Sci; 1981 Jun; 30(2):71-83. PubMed ID: 7028684
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S
    Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
    Goszcz A
    Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.